baber/WOPTO huggingface dataset:
Patent NZ-531337-A (NZ)
Title: Ocular diagnosis of alzheimer's disease
Inventor: GOLDSTEIN LEE E
IPC: G01N33/53
Filed: 2002-04-25
Abstract: A detectably-labelled compound which binds to an amyloid protein is described to be used in the manufacture of a medicament for diagnosing Alzheimer's disease. The use comprises contacting an ocular tissue with the detectably-labelled compound. An increase in binding of the compound to the ocular tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's disease.
Patent NZ-532115-A (NZ)
Title: Hybrid and fusion expression of Neisserial proteins
Inventor: PIZZA MARIAGRAZIA
IPC: C07K19/00
Filed: 2002-09-06
Abstract: Described are hybrid proteins having two or more Neisserial proteins having the formula NH2-A-[-X-L-]n-B-COOH wherein L is an optional linker amino acid sequence, A is an optional N-terminal amino acid sequence, B is an optional C-terminal amino acid sequence, n is an integer greater than 1 and X is an amino acid sequence provided as any one of SEQ ID NO: 1-22. Also described are pharmaceutical compositions comprising the hybrid proteins for treating or preventing a Neisseria s.p. infection.
Patent NZ-534675-A (NZ)
Title: Snow scooter and method of using snow scooter
Inventor: SULLIVAN DANIEL J
IPC: A63C5/03
Filed: 2003-02-06
Abstract: An apparatus is attachable to a conventional snowboard to convert the snowboard into a snow scooter having improved performance characteristics in comparison to those of the snowboard alone. The apparatus includes a member movable relative to the snowboard by either the hands or feet of the rider, and forces and motions applied to that member by the rider are converted by an associated motion and force transmitting mechanism into twisting motions of the rear portion of the snowboard relative to the front portion of the snowboard, allowing the scooter rider to better perform turns and other maneuvers during the riding of the scooter and also allowing the rider to ride the snow scooter without foot bindings fixing his feet to the scooter.
Patent NZ-534951-A (NZ)
Title: Off-load protection arrangement for semi-conductor powered illuminated display
Inventor: BRATTEL SIMON MARK
IPC: H05B45/50
Filed: 2003-02-25
Abstract: For an electrical circuit 10, having a load 20 such as an illuminated display that includes at least one semiconductor junction device 22 supplied with operating current at a voltage sufficient to bias the semiconductor junction device into conduction and a controller 30 to provide or inhibit supply of power to said load, there is provided a protection arrangement 40 including sensor circuitry 50 for sensing characteristics of the load when it is off-line, that is, when the operating current is not flowing. The sensing circuitry is coupled to the load where and when supplied with operating power and operable in the absence of such supply to sense a voltage level across the load. Threshold comparator 54 compares the sensed voltage level with at least one stored value representative of a threshold of a load characteristic delimiting consistency with semiconductor and non-semiconductor behaviour. The supply of operating current to the load is interrupted periodically for a time interval too short to be noticed, and the sensing circuitry includes a sensing current generator 62 which in the absence of operating current to the load effects passage through the load of a sensing current having a value that is less, for a semiconductor junction, than the forward conduction threshold thereof. The voltage level across the load in response to this sensing current is sensed, and threshold comparison determines if the sensed voltage level is below a value, predetermined as the minimum for said sensing current consistent with a semiconductor junction and maximum for the load having conduction characteristics from which the circuit requires protection from the application of said operating power, and the controller responds to the absence of such condition to establish or re-establish operating current to the load and to the existence of such condition to keep the load unpowered. The voltage behaviour may be used to sense other load characteristics, such as capacitance that may be due to an introduced liquid, in any interval when the load is taken off-line.
Patent NZ-536445-A (NZ)
Title: Reducing the production of fart gas by using, as an active ingredient, one or more essential oils of eugenol, limonene, a salicylate, quinoline, vanilla, thymol or a cresol
Inventor: LOSA RICCARDO
IPC: A23K1/16
Filed: 2003-04-29
Abstract: A method for reducing the production of methane emanating from the digestive activities of an animal by using one or more essential oil compounds selected from a group consisting limonene, eugenol, a salicylate, quinoline, vanilla, thymol or a cresol. The compound is then administered to the animal. Also described is a feed composition, a feed premix and a drinking water supplement.
Patent NZ-536665-A (NZ)
Title: Use of substituted phenylsulfonamide as inhibitors of beta amyloid production
Inventor: KREFT ANTHONY FRANK
IPC: C07C323/49
Filed: 2003-06-09
Abstract: Use of a pharmaceutically acceptable amount of a compound of formula (I), pharmaceutically acceptable salts, hydrates, and/or prodrugs thereof in preparation of a medicament for lowering beta amyloid levels in a subject is disclose, wherein R1-R8 are as defined in the specification. These compounds are suitable for inhibiting beta amyloid production and for the prevention and treatment of Alzheimer's Disease and Down's syndrome.
Patent NZ-537853-A (NZ)
Title: Inhibitors of cathepsin K and related cysteine protesases of the CA clan
Inventor: QUIBELL MARTIN
IPC: A61P35/00
Filed: 2003-07-15
Abstract: Disclosed herein are compounds of general formula (I) (wherein the variables are as defined in the specification), their salts, hydrates, solvates, complexes and prodrugs that are inhibitors of cathepsin K and other cysteine protease inhibitors and are useful as therapeutic agents, for example in osteoporosis, Paget's disease gingival diseases such as gingivitis and periodontitis, hypercalaemia of malignancy, metabolic bone disease, diseases involving matrix or cartilage degradation, in particular osteoarthritis and rheumatoid arthritis and neoplastic diseases. These compounds are also useful for validating therapeutic target compounds.
Patent NZ-543558-A (NZ)
Title: Avian combination-vaccine against E. coli and salmonella
Inventor: FAN HENRY H
IPC: A61K39/108
Filed: 2004-05-12
Abstract: Disclosed is an avian vaccine composition which comprises: an immunogenically effective amount of a combination of an Escherichia coli genetic deletion mutant microorganism and a Salmonella typhimurium genetic deletion mutant microorganism, and a pharmacologically acceptable carrier. More specifically disclosed is when the Escherichia coli genetic deletion mutant microorganism in the above vaccine has the identifying characteristics of E. coli aroA- PTA-5094. Also disclosed is a method for the prevention or amelioration of E. coli and Salmonella infection or disease in poultry which comprises administering to said poultry an immunogenically effective amount of a combination of an Escherichia coli genetic deletion mutant microorganism and a Salmonella typhimurium genetic deletion mutant microorganism.
Patent NZ-549381-A (NZ)
Title: Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
Inventor: MICHEL DOMINIQUE
IPC: C07B53/00
Filed: 2005-02-21
Abstract: A process for the preparation of salts of a carboxylic acid with an aminoalcohol of the formula of Ia and/or Ib wherein the substituents are disclosed in the specification. Comprising asymmetrically hydrogenating a salt of a carboxylic acid with an aminoketone of the formula wherein the substituents are defined in the specification, in the presence of a transition metal complex of a diphosphine ligand. Also disclosed are salts of a carboxylic acid said aminoketones and salts of a carboxylic acid of said aminoalcohols.
Patent NZ-551433-A (NZ)
Title: Process of preparing a canola protein isolate from canola oil seed meal
Inventor: GREEN BRENT E
IPC: A23L5/49
Filed: 2003-06-20
Abstract: Disclosed is a process of preparing a canola protein isolate from canola oil seed meal, which includes: a) extracting the canola oil seed meal to cause solubilization of the protein in the canola oil seed meal to form an aqueous protein solution having a pH of 5 to 6.8, b) separating the aqueous protein solution from residual oil seed meal, c) increasing the protein concentration of the aqueous protein solution while maintaining the ionic strength substantially constant by use of a selective membrane technique to provide a concentrated protein solution, d) pasteurizing the concentrated protein solution to form a pasteurized protein solution, e) dilution the pasteurized protein solution into chilled water having a temperature below 15øC to cause the formation of discrete protein micelles in the aqueous phase, f) settling the protein micelles to form an amorphous, sticky, gelatinous, gluten-like protein micellar mass, and g) recovering the protein micellar mass from supernatant, the protein micellar mass having a protein content of at least 90 wt% (N x 6.25) on a dry weight basis. (62) Divided Out of 537342
Patent NZ-554677-A (NZ)
Title: Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents
Inventor: SEO MIN-HYO
IPC: A61K31/475
Filed: 2005-11-04
Abstract: Disclosed is an injectable formulation for increasing the solubility of a 10-hydroxycamptothecin compound in non-aqueous polar solvent, comprising: the 10-hydroxycamptothecin compound; an amine compound whose pKa value is 7.4 or more; and a non-aqueous polar solvent.
Patent NZ-556393-A (NZ)
Title: Anti A beta antibody formulation
Inventor: LUISI DONNA
IPC: C07K16/18
Filed: 2006-01-27
Abstract: Provided is a stable formulation, comprising: (a) a humanized 3D6 monoclonal antibody at a concentration of from 0.1 mg/ml to 100 mg/ml, wherein the antibody comprises a light chain and a heavy chain comprising specified amino acid sequences; (b) histidine at a concentration of from 0.1 mM to 25 mM; (c) mannitol in an amount of from 2% w/v to 10% w/v; (d) methionine at a concentration of from 0.1 mM to 20 mM; and (e) polysorbate in an amount of from 0.001% w/v to 0.01% w/v, wherein the formulation has a pH of about 5.5 to about 6.5. Further provided are corresponding therapeutic products and methods of preparing the compositions.
Patent NZ-556627-A (NZ)
Title: Oxyindole derivatives as 5HT4 receptor agonists
Inventor: KAWAMURA KIYOSHI
IPC: A61K31/454
Filed: 2006-02-10
Abstract: Disclosed is an oxyindole derivative compound of formula (I), wherein the substituents are as defined in the specification. Compared to known indolone compounds, a quinuclidine ring has been replaced with a piperidine ring. The compounds have selective 5-HT4 receptor agonistic activity useful in the treatment of conditions such as gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageral disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders, cardiac failure, heart arrhythmia, diabetes or apnea syndrome.
Patent NZ-563467-A (NZ)
Title: Method and apparatus for wireless multi-carrier communications
Inventor: DAMNJANOVIC ALEKSANDER
IPC: H04W72/04
Filed: 2006-05-17
Abstract: A method is disclosed which includes: receiving an assignment of multiple carriers for a downlink in a Global System for Mobile Communications (GSM) network; receiving an assignment of at least one carrier for an uplink in the GSM network; and exchanging data with the GSM network via the multiple carriers for the downlink and the at least one carrier for the uplink.
Patent NZ-566559-A (NZ)
Title: Method for implementing home zone application in mobile communication networks
IPC: H04W4/24
Filed: 2008-03-11
Abstract: A method for implementing a home zone application in a mobile communication networks comprises: (a) storing a location ID for the home of a home zone user, on registration for home zone service provided by a network operator; (b) placing a positioning unit capable of short range network communication within the home zone user's home with the positioning unit being capable of calculating its location co-ordinates; (c) establishing connectivity between the positioning unit and the user's handset when said handset is present within the communication range of the positioning unit; (d) communicating the location co-ordinates of the positioning unit measured in step (b) to the handset; (e) comparing the location co-ordinates of the positioning unit of step (b) and the stored home location id of step (a); (f) determining if the handset is in the vicinity of the user's home; and (g) charging home zone tariff by a decision server in the operator's network if determined in step (f) that the handset is in the vicinity of the user's home.
Patent NZ-572860-A (NZ)
Title: A shopping system and method
Inventor: MEBRUER ROBERT
IPC: G06Q30/00
Filed: 2005-06-08
Abstract: A system for providing coupons to consumers comprises an input device for receiving an input to identify a consumer; a database for storing data relating to the characteristics of consumers, a processor for: (a) producing a coupon and providing the coupon to a consumer based on the data contained in the database; (b) providing electronically details of offers on the coupon to a redemption station so that when a consumer accepts at the redemption station offers on the coupon with the consumer receiving the offers on the coupon; and (c) providing electronically details of accepted offers on the coupon so participating parties making offers on the coupon can be billed in relation to those which are taken up by consumers; and an output device for outputting the coupon to the consumer in response to the input received by the input device. The data comprises past purchase history, attitudinal segmentation and geodemographics. (62) Divided Out of 552420
Patent NZ-580884-A (NZ)
Title: Thiazoles and pyrazoles useful as kinase inhibitors
Inventor: STUDLEY JOHN
IPC: A61K31/4427
Filed: 2008-05-02
Abstract: Disclosed herein is a compound of formula I wherein the substituents are as defined within the specification, provided that when X3 is CRx, only one of X1 and X2 is N; and provided that at least one of X1, X2 and X3 is N; methods for its preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inibitiors of Aurora protein kinases and are therefore useful in the treatment of proliferative disorders such as melanoma, myeloma, leukemia, lymphoma, neuroblastoma, or a cancer seleceted from colon, breast, gastric, ovarian, cervical, lung, central nervous system (CNS), renal, prostate, bladder, pancreatic, brain (gliomas), head and neck, kidney, liver, melanoma, sarcoma, or thyroid cancer.
Patent NZ-581569-A (NZ)
Title: Crossbar assembly for vehicle roof rack with a noise reducing member for the accessory t-slot
Inventor: ROBERTSON BRUCE JOHN
IPC: B60R9/05
Filed: 2010-11-29
Abstract: A through bar vehicle roof rack crossbar assembly (1) is disclosed. The crossbar is manufactured from an extrusion with a T-slot channel on the upper side of the crossbar when fitted to a vehicle. The crossbar includes end fittings (3) that cover each end of the crossbar, each being assembled from two caps (4, 5) that have interlinking projections. These are attached to the crossbar extrusion by way of linking projections that mate with apertures in the crossbar extrusion. Each end cap (4, 5) includes at least one aperture that is adapted to receive and retain a pin (13) when assembled and fitted to the crossbar. Use of a noise reducing members (14, 15) is also disclosed.
Patent NZ-583024-A (NZ)
Title: An agonist of miR-29a, miR-29b or miR-29c that prevents tissue fibrosis and uses thereof
Inventor: OLSON ERIC
IPC: A61P9/00
Filed: 2008-07-31
Abstract: Disclosed is the use of an agonist of miR-29a-c for the preparation of a medicament for treating or preventing a tissue fibrosis in a subject in need thereof, wherein the agonist of miR-29a-c is a polynucleotide comprising a pri-miRNA, pre-miRNA, or mature sequence of miR-29a, miR-29b, and/or miR-29c.
Patent NZ-585123-A (NZ)
Title: Subsoil and Surface chemical applicator for perennial crops
Inventor: PATON DOUGLAS
IPC: A01C23/02
Filed: 2008-11-26
Abstract: Disclosed is an applicator assembly for applying an active substance to the root zone of a plurality of plants. The applicator assembly comprises: a subsoil applicator having a cutting element (35) for generating an incision in the ground, an injector (36) associated with the cutting element to allow the active substance to be injected into the incision; and a positioning device (33) adapted to allow the position of the cutting element to change position such that an incision is generated in some material in the root zone while the cutting element moves over other material in the root zone.
Patent NZ-587522-A (NZ)
Title: Mechanism and Method for Adjustment of a Kite Control Line with activator on control bar and actuator including hydraulic circuit
Inventor: ROAKE RICHARD JOHN
IPC: B63B35/79
Filed: 2010-08-23
Abstract: The wing of a traction kite is adjusted by an activator on the control bar to activate an actuator including a hydraulic circuit.
Patent NZ-591811-A (NZ)
Title: Seed treatment agent and method for protecting plant comprising alpha-methoxyphenylacetic acid
Inventor: TAKAISHI MASANAO
IPC: A01N25/00
Filed: 2009-09-17
Abstract: Disclosed herein is a method of protecting a plant from plant diseases which comprises treating a seed of a plant with an effective amount of an alpha-methoxyphenylacetic acid compound represented by formula (1), wherein the plant is a seed or a bulb of gramineous plants, legume plants, brassicaceous plants, chenopodiaceous plants, malvaceous plant or solanaceae plants.
Patent NZ-594574-A (NZ)
Title: Oligonucleotide probes and primers for detection of hepatitis b virus
Inventor: JAGANNATH MANJULA
IPC: C12Q1/68
Filed: 2010-01-27
Abstract: Provided is an oligonucleotide probe for detecting Hepatitis B virus and corresponding primer pair and PCR kits for the same. The assay can be improved by using fluorophores conjugated to the probe.
Patent NZ-594737-A (NZ)
Title: Compositions containing amide surfactants and methods for inhibiting the formation of hydrate agglomerates
Inventor: ACOSTA ERICK J
IPC: C07D241/04
Filed: 2010-03-02
Abstract: Disclosed herein is a composition comprising a piperazinium compound, wherein the general formula and variables are defined in the specification; optionally further comprising one or more thermodynamic hydrate inhibitors, one or more kinetic hydrate inhibitors and one or more anti-agglomerates; and the use thereof in a method of inhibiting the formation of hydrate agglomerates in a fluid comprising water, gas, and optionally liquid hydrocarbon comprising adding to the fluid an effective amount of a composition produced by reacting an alkyl acrylate with 1-methylpiperazine and then subsequently reacting the resulting product with an amine, such as oleylamine, to form an amide and reacting said amide with an alkyl halide, such as 1-bromohexane.
Patent NZ-596433-A (NZ)
Title: Protein product and process for preparing injectable protein product
Inventor: FIELDING WILLIAM R
IPC: A23L13/60
Filed: 2010-11-08
Abstract: Disclosed is an animal muscle tissue protein composition for use during a food processing injection procedure with at least one injection pathway wherein the suspension comprises sarcoplasmic proteins and myofibrillar proteins derived from animal muscle tissue and obtained by the process comprising: Comminuting (breaking down, grinding, pulverising or reducing to particles or fragments) animal muscle tissueb. mixing said comminuted animal muscle protein tissue with a food grade alkaline composition to form an aqueous basic solution of animal muscle protein having a pH between about 10.5 and about 12.5. mixing said aqueous basic solution of animal muscle protein with a food grade acid composition to form an aqueous composition of animal muscle protein having a pH between about 4.7 and about 11.0, adding salt to the aqueous suspension, and comminuting said aqueous composition of animal muscle thereby to form an aqueous suspension of animal muscle protein, wherein the suspension flows through and injection pathway without blocking.
Patent NZ-598566-A (NZ)
Title: Livestock handling conveyor with identification tag reader
Inventor: MCGILLIVRAY DAVID JAME
IPC: A01K1/06
Filed: 2012-03-05
Abstract: An animal processing apparatus comprising a processing conveyor (l) for conveying an animal therealong, the conveyor including two conveyor belts (2), one on each side of a position to be occupied by an animal, and two information capture means (5) provided on the conveyor, one within each of the conveyor belts, for interrogating an identity tag on the animal. Scales (7) may be provided for weighing the animal.
Patent NZ-607678-A (NZ)
Title: Rotary displacement pump for pumping solids emulsions, especially liquid explosives
Inventor: FROMM ULRICH
IPC: F04C14/28
Filed: 2010-09-15
Abstract: A rotary displacement pump of an undulating disk type. The pump comprises a pump housing (24), a stator (40, 48), a rotor (42), a scraper (44) and a scraper guide (46). The pump housing comprises a front end plate (56) and a rear end plate. The pump housing enclosing the stator (40, 48). The pump further includes a shaft (8) extending through at least the rear end plate. The stator including a generally semi-circular arc-formed first stator member (40) and a generally semi-circular arc-formed second stator member (48). The stator, the pump housing and the scraper together with the scraper guide defining an inlet and outlet chamber, wherein at least part of the end faces of the first and second stator members being situated in the outlet chamber are oblique so as to provide an obtuse-angled transition to the inner faces of the front end plate and the rear end plate. The front and rear seal housings (50, 36) each contain a slot that allows any excess material that passes the seals to flow out of the housings. Further a gap in the security cover (64) or the spacer ring (22) allows the excess material to flow out of the pump and avoid a dangerous condition where the excess friction (caused by material build-up) can cause excessive heat that may detonate the explosive liquid/emulsion.
Patent NZ-609196-A (NZ)
Title: Monoclonal antibodies against amyloid beta protein and uses thereof
Inventor: LABKOVSKY BORIS
IPC: A61K39/395
Filed: 2006-11-30
Abstract: Disclosed is a monoclonal antibody comprising a variable heavy and light chain, wherein the three CDRs of said variable heavy chain are SEQ ID NO:5, SEQ ID NO:6 and SEQ ID NO:7, and the three CDRs of said variable light chain are SEQ ID NO:8, SEQ ID NO:9 and SEQ ID NO: 10, wherein the antibody binds with greater specificity to an amyloid beta protein globulomer than to an amyloid beta protein monomer, wherein the sequences are as defined in the complete specification. Also disclosed is the use of said antibody in the manufacture of a medicament for treating or preventing Alzheimer’s Disease. Further disclosed is a hybridoma having American Type Culture Collection designation number PTA-7238.